A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Clinical trial NCT02597868 · UNKNOWN
Trial details
- NCT number
- NCT02597868
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2016-07-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.